“I found hundreds of other people…but I still wasn’t believed” – An exploratory study on lived experiences of antipsychotic withdrawal

References

• Anderson, C., & Herxheimer, A. (2013). Harnessing patients' awareness of adverse reactions to the drugs they take. In Ziebland, S., Coulter, A., Calabrese, J., Locock, L (Eds.).,Understanding and Using Health Experiences (pp. 116–126). Oxford: Oxford Academic. https://doi.org/10.1093/acprof:oso/9780199665372.003.0012
   Google Scholar
• Begemann, M. J. H., Thompson, I. A., Veling, W., Gangadin, S. S., Geraets, C. N. W., van ‘T Hag, E., Müller-Kuperus, S. J., Oomen, P. P., Voppel, A. E., van der Gaag, M., Kikkert, M. J., Van Os, J., Smit, H. F. E., Knegtering, R. H., Wiersma, S., Stouten, L. H., Gijsman H. J., Wunderink, Lex, Staring, A. B. P., Veerman S. R. T., Mahabir A. G. S., Kurkamp, J., Pijnenborg G. H. M., Veen N. D., Marcelis, M., Grootens, K. P., Faber, G., van Beveren N. J., Been, A., van den Brink, T., Bak, M., van Amelsvoort T. A. M. J., Ruissen, A., Blanke, C., Groen, K., de Haan, L. & Sommer, I. E. C. (2020). To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial. Trials, 21(1), 147. https://doi.org/10.1186/s13063-019-3822-5
   PubMed Web of Science ®Google Scholar
• Bergström, T., Taskila, J. J., Alakare, B., Köngäs-Saviaro, P., Miettunen, J., & Seikkula, J. (2020). Five-year cumulative exposure to antipsychotic medication after first-episode psychosis and its association with 19-year outcomes. Schizophrenia Bulletin Open, 1(1). https://doi.org/10.1093/schizbullopen/sgaa050
   Google Scholar
• Bjornestad, J., Lavik, K. O., Davidson, L., Hjeltnes, A., Moltu, C., & Veseth, M. (2020). Antipsychotic treatment–a systematic literature review and meta-analysis of qualitative studies. Journal of Mental Health, 29(5), 513–523. https://doi.org/10.1080/09638237.2019.1581352
   PubMed Web of Science ®Google Scholar
• Brandt, L., Bschor, T., Henssler, J., Müller, M., Hasan, A., Heinz, A., & Gutwinski, S. (2020). Antipsychotic withdrawal symptoms: A systematic review and meta-analysis. Frontiers in Psychiatry, 11(1002). https://doi.org/10.3389/fpsyt.2020.569912
   Google Scholar
• Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
   Google Scholar
• Braun, V., & Clarke, V. (2020). One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qualitative Research in Psychology, 1–25. https://doi.org/10.1080/14780887.2020.1769238
   Web of Science ®Google Scholar
• Chiko, B. (2020). Schizophrenia medications forum. https://forum.schizophrenia.com/c/medications/3.
   Google Scholar
• Chouinard, G., & Chouinard, V. A. (2015). New classification of selective serotonin reuptake inhibitor withdrawal. Psychotherapy and Psychosomatics, 84(2), 63–71. https://doi.org/10.1159/000371865
   PubMed Web of Science ®Google Scholar
• Chouinard, G., Samaha, A. N., Chouinard, V. A., Peretti, C. S., Kanahara, N., Takase, M., & Iyo, M. (2017). Antipsychotic-induced Dopamine Supersensitivity Psychosis: Pharmacology, criteria, and therapy. Psychotherapy and Psychosomatics, 86(4), 189–219. https://doi.org/10.1159/000477313
   PubMed Web of Science ®Google Scholar
• Cooper, R. E., Grünwald, L. M., & Horowitz, M. (2020). The case for including antipsychotics in the UK NICE guideline: “Medicines associated with dependence or withdrawal symptoms: Safe prescribing and withdrawal management for adults”. Psychosis, 12(1), 89–93. https://doi.org/10.1080/17522439.2020.1722734
   Google Scholar
• Cooper, R. E., Hanratty, É., Morant, N., & Moncrieff, J. (2019). Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation. Plos One, 14(6), e0218711. https://doi.org/10.1371/journal.pone.0218711
   PubMed Web of Science ®Google Scholar
• Cooper, R. E., Laxhman, N., Crellin, N., Moncrieff, J., & Priebe, S. (2020). Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review. Schizophrenia Research, 225, 15–30. https://doi.org/10.1016/j.schres.2019.05.020
   PubMed Web of Science ®Google Scholar
• Cooper, R. E., Mason, J. P., Calton, T., Richardson, J., & Moncrieff, J. (2021). Opinion piece: The case for establishing a minimal medication alternative for psychosis and schizophrenia. Psychosis, 1–10. https://doi.org/10.1080/17522439.2021.1930119
   Google Scholar
• Cosci, F., & Chouinard, G. (2020). Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychotherapy and Psychosomatics, 89(5), 283–306. https://doi.org/10.1159/000506868
   PubMed Web of Science ®Google Scholar
• Emsley, R., Nuamah, I., Gopal, S., Hough, D., & Fleischhacker, W. W. (2018). Relapse after antipsychotic discontinuation in schizophrenia as a withdrawal phenomenon vs illness recurrence: A post hoc analysis of a randomized placebo-controlled study. The Journal of Clinical Psychiatry , 79(4), Article 17m11874. https://doi.org/10.4088/JCP.17m11874
   PubMed Web of Science ®Google Scholar
• Forsberg, N., Tai, S., & Awenat, Y. (2018). Clinician perspectives on supporting adults with psychosis who wish to discontinue neuroleptic medication: Qualitative analysis. Psychosis, 10(4), 239–250. https://doi.org/10.1080/17522439.2018.1534880
   Web of Science ®Google Scholar
• Gaebel, W., Falkai, P., & Hasan, A. (2020). The revisedgerman evidence- and consensus-based schizophrenia guideline. World Psychiatry, 19(1), 117–119. https://doi.org/10.1002/wps.20706
   PubMed Web of Science ®Google Scholar
• Geyt, G. L., Awenat, Y., Tai, S., & Haddock, G. (2016). Personal accounts of discontinuing neuroleptic medication for psychosis. Qualitative Health Research, 27(4), 559–572. https://doi.org/10.1177/1049732316634047
   PubMed Web of Science ®Google Scholar
• Greenhalgh, T., Snow, R., Ryan, S., Rees, S., & Salisbury, H. (2015). Six ‘biases’ against patients and carers in evidence-based medicine. BMC Medicine, 13(1), 200. https://doi.org/10.1186/s12916-015-0437-x
   PubMedGoogle Scholar
• Gupta, S., Cahill, J. D., & Miller, R. (2018). Deprescribing antipsychotics: A guide for clinicians. BJPsych Advances, 24(5), 295–302. https://doi.org/10.1192/bja.2018.2
   Google Scholar
• Guy, A., Davies, J., & Rizq, R. (2019). Guidance for psychological therapists: Enabling conversations with clients taking or withdrawing from prescribed psychiatric drugs. APPG for Prescribed Drug Dependence.
   Google Scholar
• Hall, W., Bergman, C., McNamara, J., & Sorensen, J. (2007). Harm reduction guide to coming off psychiatric drugs. Icarus Project.
   Google Scholar
• Harper, D. J. (2020). Framing, filtering and hermeneutical injustice in the public conversation about mental health. Journal of Constructivist Psychology, 1–15. https://doi.org/10.1080/10720537.2020.1773360
   Web of Science ®Google Scholar
• Harris, K., Brooks, H., Lythgoe, G., Bee, P., Lovell, K., & Drake, R. J. (2017). Exploring service users’, carers’ and professionals’ perspectives and experiences of current antipsychotic prescribing: A qualitative study. Chronic Illness, 13(4), 275–287. https://doi.org/10.1177/1742395317694223
   PubMed Web of Science ®Google Scholar
• Heald, A. H., Stedman, M., Farman, S., Khine, C., Davies, M., De Hert, M., & Taylor, D. (2020). Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selection. BMC Psychiatry, 20(1), 528. https://doi.org/10.1186/s12888-020-02915-3
   PubMed Web of Science ®Google Scholar
• Horowitz, M. A., Jauhar, S., Natesan, S., Murray, R. M., & Taylor, D. (2021). A method for tapering antipsychotic treatment that may minimize the risk of relapse. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbab017
   PubMed Web of Science ®Google Scholar
• Hynes, C., McWilliams, S., Clarke, M., Fitzgerald, I., Feeney, L., Taylor, M., Boland, F., & Keating, D. (2020). Check the effects: Systematic assessment of antipsychotic side-effects in an inpatient cohort. Therapeutic Advances in Psychopharmacology, 10, 2045125320957119. https://doi.org/10.1177/2045125320957119
   Web of Science ®Google Scholar
• Iacobucci, G. (2019). NICE updates antidepressant guidelines to reflect severity and length of withdrawal symptoms. British Medical Journal, 367(Oct), Article l6103. https://doi.org/10.1136/bmj.l6103
   PubMedGoogle Scholar
• Larsen-Barr, M., & Seymour, F. (2021). Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication. Therapeutic Advances in Psychopharmacology, 11, 2045125321989133. https://doi.org/10.1177/2045125321989133
   Web of Science ®Google Scholar
• Larsen-Barr, M., Seymour, F., Read, J., & Gibson, K. (2018). Attempting to discontinue antipsychotic medication: Withdrawal methods, relapse and success. Psychiatry Research, 270, 365–374. https://doi.org/10.1016/j.psychres.2018.10.001
   PubMed Web of Science ®Google Scholar
• Leucht, S., Leucht, C., Huhn, M., Chaimani, A., Mavridis, D., Helfer, B., Cipriani, A., Samara, M.,Rabaioli, M., Bächer, S., Geddes, J. R., Salanti, G., Davis J. M., & Cipriani, A. (2017). Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors. The American Journal of Psychiatry, 174(10), 927–942. https://doi.org/10.1176/appi.ajp.2017.16121358
   PubMed Web of Science ®Google Scholar
• Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E, Davis, S. M, Davis, C. E, Lebowitz, B. D, Joanne Severe, M.S, Hsiao J. K., & Lebowitz, B. D. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England Journal of Medicine, 353(12), 1209–1223. https://doi.org/10.1056/NEJMoa051688
   PubMed Web of Science ®Google Scholar
• Marston, L., Nazareth, I., Petersen, I., Walters, K., & Osborn, D. P. (2014). Prescribing of antipsychotics in UK primary care: A cohort study. BMJ Open, 4(12), e006135. https://doi.org/10.1136/bmjopen-2014-006135
   PubMed Web of Science ®Google Scholar
• Martínez-Hernáez, Á., Pié-Balaguer, A., Serrano-Miguel, M., Morales-Sáez, N., García-Santesmases, A., Bekele, D., & Alegre-Agís, E. (2020). The collaborative management of antipsychotic medication and its obstacles: A qualitative study. Social Science & Medicine, 247, 112811. https://doi.org/10.1016/j.socscimed.2020.112811
   PubMed Web of Science ®Google Scholar
• Moncrieff, J. (2006). Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal‐related relapse. Acta Psychiatrica Scandinavica, 114(1), 3–13. https://doi.org/10.1111/j.1600-0447.2006.00787.x
   PubMed Web of Science ®Google Scholar
• Moncrieff, J. (2015). Antipsychotic maintenance treatment: Time torethink? Plos Medicine, 12(8), e1001861–e1001861. https://doi.org/10.1371/journal.pmed.1001861.
   PubMed Web of Science ®Google Scholar
• Moncrieff, J., Crellin, N. E., Long, M. A., Cooper, R. E., & Stockmann, T. (2019). Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review. Schizophrenia Research. https://doi.org/10.1016/j.schres.2019.08.035
   Google Scholar
• Moncrieff, J., Gupta, S., & Horowitz, M. A. (2020). Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder. Therapeutic Advances in Psychopharmacology, 10, 2045125320937910. https://doi.org/10.1177/2045125320937910
   Web of Science ®Google Scholar
• Moncrieff, J., Lewis, G., Freemantle, N., Johnson, S., Barnes, T. R. E., Morant, N., Pinfold, V., Hunter, R., Kent, L. J., Smith, R., Darton, K., Horne, R., Crellin, N. E., Cooper, R. E., Marston, L., & Priebe, S. (2019). Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: The RADAR trial (Research into Antipsychotic Discontinuation and Reduction). BMJ Open, 9(11), e030912. https://doi.org/10.1136/bmjopen-2019-030912
   PubMed Web of Science ®Google Scholar
• Moore, J. (2020). Let’s talk withdrawal podcast. https://www.facebook.com/groups/LetsTalkWithdrawal.
   Google Scholar
• Murad, M. H., Asi, N., Alsawas, M., & Alahdab, F. (2016). New evidence pyramid. Evidence Based Medicine, 21(4), 125–127. https://doi.org/10.1136/ebmed-2016-110401
   PubMedGoogle Scholar
• NICE. (2014, March 1). Psychosis and schizophrenia in adults: Prevention and management. https://www.nice.org.uk/guidance/cg178
   Google Scholar
• Oedegaard, C. H., Davidson, L., Stige, B., Veseth, M., Blindheim, A., Garvik, L., Sørensen, J. M., Søraa, Ø., & Engebretsen, I. M. S. (2020). “It means so much for me to have a choice”: A qualitative study providing first-person perspectives on medication-free treatment in mental health care. BMC Psychiatry, 20(1), 399. https://doi.org/10.1186/s12888-020-02770-2
   PubMed Web of Science ®Google Scholar
• Read, J., & Sacia, A. (2020). Using open questions to understand 650 people’s experiences with antipsychotic drugs. Schizophrenia Bulletin, 46(4), 896–904. https://doi.org/10.1093/schbul/sbaa002
   PubMed Web of Science ®Google Scholar
• Reidenberg, M. M. (2011). Drug discontinuation effects are part of the pharmacology of a drug. The Journal of Pharmacology and Experimental Therapeutics, 339(2), 324–328. https://doi.org/10.1124/jpet.111.183285
   PubMed Web of Science ®Google Scholar
• Russo, J. (2012). Survivor-controlled research: A new foundation for thinking about psychiatry and mental health. Paper presented at the Forum Qualitative Sozialforschung/Forum: Qualitative Social Research.
   Google Scholar
• Salomon, C., Hamilton, B., & Elsom, S. (2014). Experiencing antipsychotic discontinuation: Results from a survey of Australian consumers. Journal of Psychiatric and Mental Health Nursing, 21(10), 917–923. https://doi.org/10.1111/jpm.12178
   PubMed Web of Science ®Google Scholar
• Samara, M. T., Nikolakopoulou, A., Salanti, G., & Leucht, S. (2018). How many patients with schizophrenia do not respond to antipsychotic drugs in the short term? An analysis based on individual patient data from randomized controlled trials. Schizophrenia Bulletin, 45(3), 639–646. https://doi.org/10.1093/schbul/sby095
   Web of Science ®Google Scholar
• Slade, M. (2017). Implementing shared decision making in routine mental health care. World Psychiatry, 16(2), 146–153. https://doi.org/10.1002/wps.20412
   PubMed Web of Science ®Google Scholar
• Steingard, S. (2018). Fiveyear outcomes of tapering antipsychotic drug doses in a community mental health center. Community Mental Health Journal, 54(8), 1097–1100. https://doi.org/10.1007/s10597-018-0313-1
   PubMed Web of Science ®Google Scholar
• Timms, P. (2020). Stopping antidepressants. London. https://www.rcpsych.ac.uk/docs/default-source/mental-health/treatments-and-wellbeing/print-outs/stopping-antidepressant-printable.pdf?sfvrsn=2c9a63e0_2
   Google Scholar
• White, E., Read, J., & Julo, S. (2021). The role of facebook groups in the management and raising of awareness of antidepressant withdrawal: Is social media filling the void left by health services? Therapeutic Advances in Psychopharmacology, 11, 2045125320981174. https://doi.org/10.1177/2045125320981174
   Web of Science ®Google Scholar
• Wunderink, L. (2019). Personalizing antipsychotic treatment: Evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders. Therapeutic Advances in Psychopharmacology, 9, 2045125319836566. https://doi.org/10.1177/2045125319836566
   Web of Science ®Google Scholar